Statement regarding Centrica Chairman
Source: RNS12th February 2020
Centrica plc
('The Company')
Board Announcement
Statement regarding Charles Berry, Centrica Chairman
Centrica plc (the 'Company') announces that, due to an unanticipated medical condition, the Company's Chairman, Charles Berry, is taking a leave of absence.
We wish him well and expect him to return to his duties shortly. Until his return, Scott Wheway will be acting as interim Chairman.
ENDS
Enquiries:
Investors/analysts 01753 494900 ir@centrica.com
Media 01784 843000 media@centrica.com
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
